TRAX · First Tracks Biotherapeutics, Inc. · Executive Compensation
$33.28
-0.64 (-1.89%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$1.23B
Shares
35.73M
Volume · Oct 2
1.17M
Avg daily vol (3M)
786.99K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ajim Tamboli | Chief Financial Officer | Appointed | 2026-04-20 |